Alector announces appointment of elizabeth a. garofalo, m.d.

South san francisco, calif., sept. 28, 2021 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the addition of elizabeth (betsy) a. garofalo, m.d., to the company's board of directors. dr. garofalo is a veteran biopharmaceutical executive with more than 25 years of experience in global clinical development and regulatory affairs, with a focus on neurology.
ALEC Ratings Summary
ALEC Quant Ranking